Ovid pauses phase 2 plans for ROCK2 inhibitor to mull mixed data from Recursion's rival drug 0 13.11.2024 14:16 Fiercebiotech.com Ovid pauses phase 2 plans for ROCK2 inhibitor to mull mixed data from Recursion's rival drug jwaldron Wed, 11/13/2024 - 06:16
